1. Home
  2. ADSK vs NTRA Comparison

ADSK vs NTRA Comparison

Compare ADSK & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Autodesk Inc.

ADSK

Autodesk Inc.

HOLD

Current Price

$234.94

Market Cap

45.8B

Sector

Technology

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$270.88

Market Cap

39.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADSK
NTRA
Founded
1982
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.8B
39.1B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
ADSK
NTRA
Price
$234.94
$270.88
Analyst Decision
Buy
Strong Buy
Analyst Count
26
15
Target Price
$335.04
$259.07
AVG Volume (30 Days)
2.1M
1.1M
Earning Date
05-21-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
2.15
0.65
EPS
2.32
N/A
Revenue
$7,206,000,000.00
$210,939,000.00
Revenue This Year
$15.35
$18.08
Revenue Next Year
$10.36
$19.65
P/E Ratio
$105.71
N/A
Revenue Growth
17.53
N/A
52 Week Low
$185.50
$131.81
52 Week High
$329.09
$288.04

Technical Indicators

Market Signals
Indicator
ADSK
NTRA
Relative Strength Index (RSI) 70.60 46.11
Support Level $227.17 $186.96
Resistance Level $251.98 $256.36
Average True Range (ATR) 8.51 10.28
MACD 4.05 -4.28
Stochastic Oscillator 91.78 16.16

Price Performance

Historical Comparison
ADSK
NTRA

About ADSK Autodesk Inc.

Founded in 1982, Autodesk is a multinational software company best known for pioneering computer-aided design, or CAD, with its AutoCAD product. Nowadays, Autodesk provides design software for a variety of verticals, including architecture & construction, manufacturing, and media & entertainment. Autodesk products have been used in some of the world's most iconic landmarks, like Burj Khalifa, and well-known movie titles like Avatar.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: